华海药业：第三季度净亏损2913.13万元

Core Viewpoint - Huahai Pharmaceutical reported a decline in both revenue and net profit for the third quarter and the first three quarters of the year, indicating ongoing financial challenges for the company [1]. Financial Performance Summary - In the third quarter, the company achieved revenue of 1.893 billion yuan, a year-on-year decrease of 10.70% [1]. - The net loss attributable to shareholders for the third quarter was 29.13 million yuan, representing a year-on-year decline of 110.30% [1]. - For the first three quarters, the company reported total revenue of 6.409 billion yuan, down 11.57% year-on-year [1]. - The net profit attributable to shareholders for the first three quarters was 380 million yuan, a decrease of 63.12% compared to the previous year [1].